MoneyWorks4Me

Raymed Labs informs about quarterly statement of investor complaints

12 Jul 2016 Evaluate

Raymed Labs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Uflex 607.90
EPL 230.95
AGI Greenpac 725.60
Huhtamaki India 238.40
TCPL Packaging 4165.25
View more..